Alchemab Therapeutics secured £25m (=$34m) from the British Business Bank, described as the Bank’s largest investment in a life sciences company to date. The funding is a positive financing milestone, supporting biotech development prospects though it is unlikely to have broad market impact.
Alchemab Therapeutics secured £25m (=$34m) from the British Business Bank, described as the Bank’s largest investment in a life sciences company to date. The funding is a positive financing milestone, supporting biotech development prospects though it is unlikely to have broad market impact.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
mildly positive
Sentiment Score
0.35
Ticker Sentiment
